Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
SAN DIEGO, Sept. 4, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's President and CEO Ted Schroeder will present the company's corporate overview on Wednesday, September 11, 2013 at 3:50pm Eastern Time (12:50pm Pacific Time) during the Stifel Nicolaus Healthcare Conference 2013 at Four Seasons Hotel in Boston.
The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the Investors page of www.cadencepharm.com under "Events & Presentations" by selecting "Corporate Overview."
William R. LaRue
Cadence Pharmaceuticals, Inc.
SOURCE Cadence Pharmaceuticals, Inc.
More by this Source
Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation
Nov 14, 2013, 18:54 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.